Continuous Non-invasive Blood Pressure Measurement in C-section
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jan 11, 2018
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
The determination of arterial blood pressure is a basic monitoring measure during spinal anaesthesia in obstetrics for the operative delivery of the child via the caesarean section. Adequate arterial blood pressure is essential to ensure adequate placental perfusion, sufficient cerebral perfusion pressure of the mother and is the basis for any hemodynamic optimization to significantly improve patient outcome.
Up to now, two standard methods for determining blood pressure have always been the oscillating non-invasive, intermittent blood pressure measurement (NIBP) and the invasive continuou...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients who receive a caesarean section under spinal anaesthesia
- • Presence of the written declaration of consent
- • Age \>/= 18 years
- • No participation in another prospective intervention study during participation in this study
- Exclusion Criteria:
- • Symptomatic heart failure NYHA \>/= III (New York Heart Association)
- • Symptomatic valve disease (stenosis/insufficiency) \>/= II°
- • Liver failure CHILD \>/= B
- • Acute or chronic renal impairment requiring dialysis
- • (pre-)clampsia
- • HELLP syndrome
- • current or previous alcohol or drug abuse
- • Psychiatric diseases
- • sepsis
- • side difference of the blood pressure measured during screening for vascular pathologies with blood pressure \>12mmHg by means of NIBP
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Sascha Treskatsch, MD, Prof
Principal Investigator
Charite
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials